Gerresheimer Stock - weekly sector review and peer comparison
19.06.2026 - 21:52:49 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 21:45 CET. Details in the imprint.
Gerresheimer (DE000A0LD6E6) closes the week without a new ad-hoc release or major wire headline shaping the narrative. With no fresh catalyst reported by leading financial sources today, the focus shifts to its sector position and recent analyst expectations.
All news and key data on Gerresheimer stock
Stay on top of Gerresheimer with a bundled view of recent corporate disclosures, market data and sector context.
What Reuters and peers highlight
No new Gerresheimer-specific update has appeared on the company’s investor relations page or on the major news wires on 06/19/2026, according to today’s ad hoc news sector overview. The latest ad hoc news stock note instead emphasizes the broader healthcare packaging environment.
The same overview points out that sector sentiment has been shaped more by macro drivers like healthcare spending and drug pipeline trends than by issuer-specific headlines for Gerresheimer. A related sector review underlines that this week’s trading in several peer names was also driven mainly by index flows and rate expectations.
Weekly review and sector comparison
Gerresheimer is positioned at the crossroads of pharmaceutical packaging and medical technology services, serving global drugmakers with vials, syringes and related solutions. Company materials describe a portfolio that straddles specialty glass, plastic systems and drug delivery.
Within the MDAX and the broader Stoxx Europe 600 healthcare names, Gerresheimer sits in the mid-cap bracket, with an earlier ad hoc news snapshot putting its market capitalization around EUR 3.2 billion as of a recent reference date. The previous sector piece framed the stock as a way to access demand for injectable drugs and biologics packaging rather than a broad healthcare bet.
The product behind the stock
Gerresheimer’s core business is the development and production of primary packaging and drug delivery systems for the pharmaceutical and biotech industries. This includes glass and plastic vials, prefillable syringes, cartridges and complex systems that enable safe storage and administration of medications.
Where the stock trades today
The shares of Gerresheimer (DE000A0LD6E6) trade on Xetra at EUR 25.64 as of 06/19/2026, 21:45 CET.
Key facts on Gerresheimer stock
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Venue: Xetra
- Price (as of 06/19/2026, 21:45 CET): 25.64 EUR
- Market cap: 3,200,000,000 EUR (as of 06/19/2026)
- Sector / Industry: Health Care - Medical Supplies & Pharmaceuticals Packaging
- Index membership: MDAX, Stoxx Europe 600
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
